| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/19/2006 | US20060014258 DNA coding for a protein which imparts L-homoserine resistance to Escherichia coli bacterium, and a method for producing L-amino acids |
| 01/19/2006 | US20060014254 Albumin fusion proteins |
| 01/19/2006 | US20060014253 Lamprey GnRH-III polypeptides and methods of making thereof |
| 01/19/2006 | US20060014252 Flk-1 binding protein |
| 01/19/2006 | US20060014251 Alternatively spliced isoform of calcium channel, voltage dependent, alpha-II subunit (CACNA1I) |
| 01/19/2006 | US20060014249 Human G-protein coupled receptor |
| 01/19/2006 | US20060014248 Tumor Necrosis Factor Super Family (TNFSF) with antagonist activity ; for autoimmune conditions |
| 01/19/2006 | US20060014246 Canine cold- and menthol-sensitive receptor 1 |
| 01/19/2006 | US20060014244 Novel nucleic acid sequences encoding adenylate kinase, phospholipid scramblase-like, DNA fragmentation factor-like, phosphatidylserine synthase-like, and ATPase-like molecules and uses therefor |
| 01/19/2006 | US20060014243 Human G-protein chemokine receptor HSATU68 |
| 01/19/2006 | US20060014242 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
| 01/19/2006 | US20060014241 Extended glucagon-like peptide-1 analogs |
| 01/19/2006 | US20060014234 Protected phosphorylated proteins or peptides are captured by reaction with a diazo moiety linked to a separation medium, isolated from the non-phosphorylated components of the mixture, released from the separation medium, and subsequently characterized by physicochemical means |
| 01/19/2006 | US20060014233 Methods for measuring ADAMTS13 activity and protein on platelets and in plasma |
| 01/19/2006 | US20060014226 Nucleic acid and amino acid sequences of hemoglobin-response genes in Candida albicans and the use of reagents derived from these sequences in the diagnosis of disseminated Candida albicans infection |
| 01/19/2006 | US20060014222 Antibodies |
| 01/19/2006 | US20060014217 Sphingomyelin detecting probe |
| 01/19/2006 | US20060014216 Prophylaxis, therapy of Alzheimer's disease; using phenothiazine compound such as methylene blue |
| 01/19/2006 | US20060014210 Reacting with 2-methoxy-4,5-dihydro-1H-imidazole; determining amino acid sequence; improved data quality |
| 01/19/2006 | US20060014208 Functional assays for identifying compounds that modulate T1R2/T1R3 (sweet) taste |
| 01/19/2006 | US20060014206 Assay methods for state-dependent calcium channel agonists/antagonists |
| 01/19/2006 | US20060014204 Methods of inducing formation of functional and organized lymphatic vessels |
| 01/19/2006 | US20060014201 Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof |
| 01/19/2006 | US20060014191 Analog probe complexes |
| 01/19/2006 | US20060014173 PR/SET-domain containing nucleic acids, polypeptides, antibodies and methods of use |
| 01/19/2006 | US20060014166 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of endometriosis |
| 01/19/2006 | US20060014159 Methods of determining precise HERG interactions and designing compounds based on said interactions |
| 01/19/2006 | US20060014148 Igg fc/hiv-gp120/c3d fusion protien |
| 01/19/2006 | US20060014140 Molecular methods and compositions for detecting and quantifying respiratory viruses |
| 01/19/2006 | US20060014139 Which comprises three N-helices and at least two, but not three, of the three C-helices of the trimer-of-hairpin structure of HIV gp41; inhibits infection of cells; drug screening; gene therapy |
| 01/19/2006 | US20060013883 Poloxamer and poloxamine compositions for nucleic acid delivery |
| 01/19/2006 | US20060013832 Methods for treating HIV infected subjects |
| 01/19/2006 | US20060013831 adjuvant peptide and heterologous an antigen; human immunodeficiency virus (HIV)-related peptides; antigen is cholera toxin; fusion protein |
| 01/19/2006 | US20060013826 Recombinant measles viruses expressing epitopes of antigens of RNA viruses - use for the preparation of vaccine compositions |
| 01/19/2006 | US20060013823 Administering LK6/68 proteins in which sequence is identical to apolipoprotein kringle domains to reduce tumor growth; recombinant Escherichia; for treatment of cancer, rheumatoid arthritis, and psoriasis |
| 01/19/2006 | US20060013822 Utilization of mhc class II binding motifs in immunization to produce immune, serum, monoclonal antibodies and vaccines |
| 01/19/2006 | US20060013820 Antigen delivery vectors and constructs |
| 01/19/2006 | US20060013817 identification of genetic products that are expressed in association with a tumor and the nucleic acid coding therefor. The invention relates to the therapy and diagnosis of diseases in which said genetic products that are expressed in association with a tumor are expressed in an aberrant manner. |
| 01/19/2006 | US20060013816 IgG4 constant region; Fab' fragment; antibody or antigen binding fragment inhibits binding of A2 or cA2 to human TNF- alpha , and binds to a neutralizing epitope of human TNF- alpha |
| 01/19/2006 | US20060013815 Human Mob-5 (IL-24) receptors and uses thereof |
| 01/19/2006 | US20060013813 Proteins and nucleic acids encoding same |
| 01/19/2006 | US20060013808 Treatment for asthma |
| 01/19/2006 | US20060013803 Modified dendritic cells |
| 01/19/2006 | US20060013800 Stable immunogenic product comprising antigenic heterocomplexes |
| 01/19/2006 | DE19930676B4 Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln A method of stabilizing insulin, insulin derivatives and / or precursors thereof in complex mixtures for storage thereof in aqueous solvents |
| 01/19/2006 | DE10247755B4 Selektive, lokale Aktivierung von Mitgliedern der TNF-Rezeptorfamilie durch systemisch inaktive nicht-Antikörper-TNF-Liganden-Fusionsproteine Selective, local activation of members of the TNF receptor family by systemically inactive non-antibody-TNF-ligand fusion proteins |
| 01/19/2006 | DE102004027335A1 Sequenzen für die Synthese antibakteriell wirkender Polyketide Sequences for the synthesis of antibacterial polyketide |
| 01/19/2006 | DE102004025452A1 Vakzine enthaltend BVDV Vaccine containing BVDV |
| 01/19/2006 | CA2614382A1 Homo and heterodimer proteins of the abcg family, methods for detection and screening modulators thereof |
| 01/19/2006 | CA2573443A1 Plants having improved growth characteristics and method for making the same |
| 01/19/2006 | CA2573377A1 Reagents for diagnosis and therapy of latex allergy and method for the preparation of the same |
| 01/19/2006 | CA2572984A1 A pharmaceutical composition containing polypeptide fragments of the serralysins |
| 01/19/2006 | CA2572873A1 Inhibitors based on fusion, hr1 and hr2 sequences in bacterial adhesin |
| 01/19/2006 | CA2553436A1 Peptides selectively lethal to malignant and transformed mammalian cells |
| 01/19/2006 | CA2544692A1 Anti-glypican 3 antibody |
| 01/18/2006 | EP1617218A1 METHOD OF SCREENING DRUG WITH THE USE OF 67 kDa LAMININ RECEPTOR AND DRUG OBTAINED THEREBY |
| 01/18/2006 | EP1617216A1 Novel method of screening |
| 01/18/2006 | EP1616963A2 Process for producing dipeptides or dipeptide derivatives |
| 01/18/2006 | EP1616961A1 Vectors and methods for gene transfer to cells |
| 01/18/2006 | EP1616960A2 Human pancreatic cell lines: developments and uses |
| 01/18/2006 | EP1616958A2 Notch-ligands for use in immunotherapy |
| 01/18/2006 | EP1616956A1 Cell death-inducing fused gene acting specifically on cancer and gene product thereof |
| 01/18/2006 | EP1616954A2 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 01/18/2006 | EP1616953A1 Method of detecting beta 3 adrenaline receptor mutant gene and nucleic acid probe and kit therefor |
| 01/18/2006 | EP1616950A1 Peptide having htlv-1-specific ctl-inducing activity |
| 01/18/2006 | EP1616942A2 Patched genes and their use |
| 01/18/2006 | EP1616884A2 Zcytor7 cytokine receptor and antibody thereto |
| 01/18/2006 | EP1616883A2 Antibodies against VLA-4 |
| 01/18/2006 | EP1616882A2 Apo-2 receptor antibodies |
| 01/18/2006 | EP1616879A2 Human cub-domain-containing protein and gene encoding the same |
| 01/18/2006 | EP1616878A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/18/2006 | EP1616877A1 Reagents for diagnosis and therapy of latex allergy and method for the preparation of the same |
| 01/18/2006 | EP1616876A2 A method for identification, isolation and production of antigens to a specific pathogen |
| 01/18/2006 | EP1616875A1 GD3-mimetic peptides |
| 01/18/2006 | EP1616580A2 Alpha-amylase transcription factor |
| 01/18/2006 | EP1616579A1 CD40 binding molecules and CTL peptides for treating tumors |
| 01/18/2006 | EP1616578A1 Compositions and methods for delivery of genetic material |
| 01/18/2006 | EP1616575A1 Method for treating inflammation |
| 01/18/2006 | EP1616194A2 Secreted polypeptide species associated with cardiovascular disorders |
| 01/18/2006 | EP1616186A2 Fragments of fluorescent proteins for protein fragment complementation assays |
| 01/18/2006 | EP1616183A2 Methods of detecting neurological disorders |
| 01/18/2006 | EP1616181A2 Polypeptides related to natriuretic peptides and methods of their identification and use |
| 01/18/2006 | EP1616021A2 Multiplex polymer ligation |
| 01/18/2006 | EP1616019A2 Method for extracting collagen comprising microbial fermentation |
| 01/18/2006 | EP1616016A2 Gene therapy vectors having reduced immunogenicity based on cd8 alpha-chain |
| 01/18/2006 | EP1616014A2 Method to increase stress tolerance in plants |
| 01/18/2006 | EP1616011A2 Chimeric polypeptides and their use |
| 01/18/2006 | EP1616010A2 Cytokine polypeptides and antibodies containing a signal sequence for the attachment of glycosylphosphatidylinositol |
| 01/18/2006 | EP1616007A1 Inhibitor proteins of a protease and use thereof |
| 01/18/2006 | EP1616003A1 Water-soluble thioester and selenoester compounds and methods for making and using the same |
| 01/18/2006 | EP1616002A2 Method for obtaining mastocyte lines from porcine tissue and method for production of heparin type molecules |
| 01/18/2006 | EP1616000A1 Expression of proteins in cord blood-derived endothelial cells |
| 01/18/2006 | EP1615996A2 Uses of vascular endothelial growth factor and type i collagen inducible protein (vcip) |
| 01/18/2006 | EP1615991A2 Polynucleotide encoding a novel human p2x7 splice variant, hbmyp2x7v |
| 01/18/2006 | EP1615954A2 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia |
| 01/18/2006 | EP1615953A2 Agent comprising an albumin-like first polypeptide bound to a second polypeptide |
| 01/18/2006 | EP1615952A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
| 01/18/2006 | EP1615951A2 Method for identifying an anti-streptococcal agent and its use for treating streptococcal infections |
| 01/18/2006 | EP1615950A2 S. pneumoniae antigens |
| 01/18/2006 | EP1615945A2 Glycopegylation methods and proteins/peptides produced by the methods |